We use Cookies to help give you the best experience on our site. To find out more about our use of cookies you can visit our privacy policy. If you continue to use this site, you are accepting our use of cookies.

September 2011

BioVigilant Submits Drug Master Files to U.S. FDA for
Instantaneous Microbial Detections Systems

TUCSON, AZ – September 1, 2011 – BioVigilant Systems, Inc., (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today it has filed Type V Drug Master Files (DMFs) for its IMD-A® 300 series of rapid biologic detection systems for real-time environmental air monitoring in pharmaceutical manufacturing environments.

The DMF submissions contain information the Federal Drug Administration (FDA) can review to approve the use of BioVigilant’s equipment in the manufacturing, processing, packaging or storage of drug products. Included in the filings are the test protocols and results of BioVigilant’s extensive testing against the USP<1223> Validation of Alternative Microbiological Methods guideline; environmental, vibration and shock test results; a review of the IMD-A systems’ technology, functionality, subsystems, and operation; and BioVigilant’s IQ/OQ/PQ protocols.

BioVigilant’s IMD-A 300 and IMD-A 350 systems can detect immediately the presence of bacteria in the drug manufacturing process, and in doing so, greatly accelerate the quality assurance processes for drug batch release. In addition, the systems may be used as constant monitors throughout the entire production period in contrast to other equipment which may be used for spot checks.

About Azbil BioVigilant

With headquarters in Tucson, Arizona, Azbil BioVigilant invented instantaneous microbial detection technology to address environmental monitoring needs in the pharmaceutical, biotechnology, healthcare, and environmental applications. Azbil BioVigilant’s IMD systems detect – instantaneously and in real-time – particle count, size, and biological status. Unlike other rapid microbial methods, Azbil BioVigilant’s optically-based systems require no staining, no reagents, no waiting period, and little human intervention. The company holds 19 patents with an additional 37 applications pending. Azbil BioVigilant’s parent company is Azbil Corporation of the Azbil Group, part of the TOPIX Mid400 traded on the Tokyo Stock Exchange. For more information, go to www.biovigilant.com.

About Azbil Group

The Azbil Group consists of Azbil Corporation and its affiliate and subsidiary companies. The Azbil Group has operations in 18 countries worldwide and more than 9,500 employees. For detailed information, visit www.azbil.com.

Trademark Notice

IMD-A®, IMD-W™, BioVigilant®, the BioVigilant logo, and the term Instantaneous Microbial Detection™ are the trademarks or registered trademarks of Azbil BioVigilant, Inc. in the United States and/or other countries. Other names or brands may be the property of others.

For More Information

Contact Mary Parsons, BioVigilant Systems, mparsons@biovigilant.com, 520-292-2342.

published at Friday, November 16th, 2018